Unfractionated heparin is associated with a lower rise of serum vascular cell adhesion molecule-1 in acute ischemic stroke patients

被引:34
作者
Chamorro, A
Cervera, A
Castillo, J
Dávalos, A
Aponte, JJ
Planas, AM
机构
[1] Hosp Clin Univ, Serv Neurol, Barcelona 08036, Spain
[2] Complejo Hosp Univ, Dept Neurol, Santiago De Compostela 15706, Spain
[3] Hosp Univ Doctor Josep Trueta, Neurol Sect, Girona 17001, Russia
[4] Hosp Clin Univ, Barcelona 08036, Spain
[5] CSIC, IIBB, Dept Pharmacol & Toxicol, Barcelona 08036, Spain
关键词
cerebrovascular disease; heparin; aspirin; cytokines; vascular cell adhesion molecule-1; inflammation; outcome;
D O I
10.1016/S0304-3940(02)00518-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We sought to assess the anti-inflammatory properties of unfractionated heparin (UFH) in patients with ischemic stroke treated within 24 h from the onset of symptoms. We studied prospectively 167 patients that received 1000 IU/h intravenous UFH (n = 70) or 300 mg oral aspirin (n = 97) at a mean treatment delay of 6.7 h. Repeated plasma levels of interleukin (IL)-6, IL-10, IL-4, tumor necrosis factor (TNF)-alpha, soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1) were compared in both groups using multivariate analyses. Whereas TNF-alpha and sICAM-1 decreased at 48 h, IL-6, IL-4, and sVCAM-1 increased compared with baseline values (P < 0.01). The rise of sVCAM-1 levels at 48 h was significantly lower in patients treated with UFH (P = 0.017) and a two-fold increase of baseline sVCAM-1 was an independent predictor of poor outcome (odds ratio, 2.19,1.1-4.39). These results suggest that adjusted high-dose UFH has anti-inflammatory effects which might improve recovery if administered early after stroke onset. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:229 / 232
页数:4
相关论文
共 21 条
[11]  
Gori AM, 1999, THROMB HAEMOSTASIS, V81, P589
[12]   Dichotomizing stroke outcomes based on self-reported dependency [J].
Kay, R ;
Wong, KS ;
Perez, G ;
Woo, J .
NEUROLOGY, 1997, 49 (06) :1694-1696
[13]  
Kishimoto T K, 1994, Adv Pharmacol, V25, P117, DOI 10.1016/S1054-3589(08)60431-7
[14]  
McGilvray ID, 1997, J BIOL CHEM, V272, P10287
[15]   Heparin blunts endotoxin-induced coagulation activation [J].
Pernerstorfer, T ;
Hollenstein, U ;
Hansen, JB ;
Knechtelsdorfer, M ;
Stohlawetz, P ;
Graninger, W ;
Eichler, HG ;
Speiser, W ;
Jilma, B .
CIRCULATION, 1999, 100 (25) :2485-2490
[16]   HEPARIN INDUCES RELEASE OF EXTRINSIC COAGULATION PATHWAY INHIBITOR (EPI) [J].
SANDSET, PM ;
ABILDGAARD, U ;
LARSEN, ML .
THROMBOSIS RESEARCH, 1988, 50 (06) :803-813
[17]   Inflammation and glial responses in ischemic brain lesions [J].
Stoll, G ;
Jander, S ;
Schroeter, M .
PROGRESS IN NEUROBIOLOGY, 1998, 56 (02) :149-171
[18]   EARLY INTRATHECAL PRODUCTION OF INTERLEUKIN-6 PREDICTS THE SIZE OF BRAIN LESION IN STROKE [J].
TARKOWSKI, E ;
ROSENGREN, L ;
BLOMSTRAND, C ;
WIKKELSO, C ;
JENSEN, C ;
EKHOLM, S ;
TARKOWSKI, A .
STROKE, 1995, 26 (08) :1393-1398
[19]  
Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8
[20]  
von Andrian UH, 2000, LEUKOCYTE RECRUITMENT, ENDOTHELIAL CELL ADHESION MOLECULES, AND TRANSCRIPTIONAL CONTROL, P55